Generics- Innovation or Re-innovation

Conventionally, generic medicines are perceived as mere copies of the original products. However, the generics of today are so much more than that. Year 2021, was another successful and productive year in pursuit of mission to help ensure high-quality, affordable generic drugs are readily available. Even with the unique challenges caused by the ongoing Covid pandemic, office of Generic Drugs continued to innovate and conduct scientific research to keep the FDA generic drug program moving forward. The FDA’s generic drug program approved hundreds of generic drug applications and thousands of supplements to already approved ANDAs.

With the declining innovativeness of the classic R & D model in the original pharmaceutical industry, the generic pharmaceutical industry is aiming to become an innovation generator.